Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polypoidal Choroidal Vasculopathy”

60 trials

Showing 20 of 60 results

Not applicableStudy completedNCT03941587
What this trial is testing

Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment

Who this might be right for
Polypoidal Choroidal Vasculopathy
Singapore National Eye Centre 60
Not applicableUnknownNCT02815176
What this trial is testing

Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers

Who this might be right for
Central Serous ChorioretinopathyPolypoidal Choroidal Vasculopathy
Samsung Medical Center 100
Not applicableStudy completedNCT04714242
What this trial is testing

OCTA and Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Federico II University 60
Post-approval studies (Phase 4)Study completedNCT02120950
What this trial is testing

Aflibercept in Polypoidal Choroidal Vasculopathy

Who this might be right for
Neovascular Macular Degeneration
Bayer 333
Post-approval studies (Phase 4)Study completedNCT00331435
What this trial is testing

PDT Study for Exudative AMD With PCV

Who this might be right for
Age Related Macular Degeneration
Ophthalmic PDT Study Group 113
Testing effectiveness (Phase 2)Study completedNCT01469156
What this trial is testing

Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Southeast Retina Center, Georgia 20
Post-approval studies (Phase 4)UnknownNCT04380974
What this trial is testing

Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Xiaodong Sun 102
Not applicableStudy completedNCT04075188
What this trial is testing

Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid

Who this might be right for
Choroidal NeovascularizationChoroid Disease
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo 17
Not applicableUnknownNCT04101604
What this trial is testing

Biomarkers of Common Eye Diseases

Who this might be right for
UveitisDiabetic RetinopathyAge-related Macular Degeneration+3 more
Sun Yat-sen University 220
Post-approval studies (Phase 4)Study completedNCT02860858
What this trial is testing

Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Symtomatic Macular Polypoidal Choroidal Vasculopathy
Department of Medical Services Ministry of Public Health of Thailand 50
Not applicableEnded earlyNCT02857894
What this trial is testing

Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)

Who this might be right for
Choroidal Neovascularization
Fondation Ophtalmologique Adolphe de Rothschild 7
Not applicableStudy completedNCT04836143
What this trial is testing

Eyes That Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion

Who this might be right for
Age-related Macular Degeneration
Kim's Eye Hospital 512
Testing effectiveness (Phase 2)UnknownNCT01248117
What this trial is testing

Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Retina Consultants of Hawaii 20
Large-scale testing (Phase 3)UnknownNCT00344617
What this trial is testing

Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy

Who this might be right for
Choroidal NeovascularisationPolypoidal Choroidal Vasculopathy
Singapore National Eye Centre 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06550011
What this trial is testing

Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Neovascular (Wet) AMD
Avirmax Biopharma Inc 18
Not applicableStudy completedNCT05229237
What this trial is testing

Conbercept for Polypoidal Choroidal Vasculopathy（START Study）

Who this might be right for
Polypoidal Choroidal VasculopathyConbercept
Peking Union Medical College Hospital 500
Not applicableUnknownNCT04707027
What this trial is testing

Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept

Who this might be right for
Polypoidal Choroidal Vasculopathy
Chiang Mai University 80
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Not applicableUnknownNCT01360151
What this trial is testing

Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Seoul St. Mary's Hospital 16
Not applicableStudy completedNCT03929731
What this trial is testing

Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy
Singapore National Eye Centre 72
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation